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ABSTRACT: Pluronics (tri-block copolymers) have a significant role in the
pharmaceutical industry and are being used to enhance the solubility and
delivery of hydrophobic drugs in different marketed formulations. However,
instability and unsatisfactory drug-loading capacity are the major weak spots of
these pluronic micelles. The present research work is designed to solve the
existing issues by the solubilization study of hydrophobic drugs in different
pluronic micelles at variable temperatures. The solubilization of the hydrophobic
antiepileptic drug lamotrigine (LAM) in five different pluronic micelles viz. P84,
P85, F127, F108, and F68 was studied at different temperatures, 37, 47, and 57
°C, using UV−visible spectroscopy. The solubilization of LAM in pluronic
micelles increased with the increase in temperature. Small-angle neutron
scattering (SANS) measurements were used to observe the morphological and
structural changes taking place in pluronics by increasing the temperature. The
SANS results showed the morphological changes of spherical P84 micelles to prolate ellipsoidal micelles at 57 °C due to
remarkable increase in the aggregation number. This morphological conversion was further confirmed by the heat transfer
method (HTM) and dynamic light scattering (DLS) measurements. DLS measurements confirmed that LAM-loaded micelles
showed a greater hydrodynamic diameter (Dh) compared to unloaded micelles, assuring LAM solubilization in the pluronic
micelles. The rate of controlled release of LAM from five different pluronic micelles was accessed by using different kinetic
models to evaluate the in vitro release profile. This is the first report in which HTM measurements are established for the
analysis of morphological changes in the thermoresponsive pluronic micelles in real time. The present work corroborates how
we can control the drug-loading capacity, morphological structure of the drug carrier, as well as drug release by simply changing
the temperature of pluronic micellar media.
1. INTRODUCTION
Poor water solubility of drugs is the most important hurdle in
the pharmaceutical industry and research. The development of
better formulations of approved drugs is one of the most
successful strategies of scientific and industrial importance.1−3
In this context, delivery of hydrophobic drug via pluronic
micelles is an interesting alternative. Pluronics, triblock
copolymers, are US-FDA approved excipients for many
marketed formulations and are currently used in parenteral
injections. Pluronics consist of hydrophilic block poly-
(ethylene oxide) (PEO) and hydrophobic block poly-
(propylene oxide) (PPO) in a triblock structure of PEO−
PPO−PEO. The hydrophilic PEO block of the pluronic
micelle is effective against serum protein adsorption, which
improves the stability of the nanomicellar system and
increases drug delivery. Pluronics play a significant role in
pharmaceutical performance to increase the solubility,
bioavailability, release, and stability of hydrophobic drug
molecules.4−8 Pluronics modulate the drug efflux transporter
P-glycoprotein on the blood brain barrier (BBB) results in the
enhancement the BBB penetration of pluronic-loaded hydro-
phobic drugs. According to recent findings, in the drug
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resistance, P-glycoproteins are over-expressed and pluronics
can act as modulators of P-glycoproteins; hence, as a drug
carrier for the treatment of multidrug-resistant diseases,
pluronic micellar formulations can be useful.9−13
Lamotrigine (LAM), 3,5-diamino-6-(2,3-dichlorophenyl)-
1,2,4-tria-zine, is a novel antiepileptic drug, and it is also
used in the treatment of primary and secondary tonic−clonic
seizures and seizures associated with Lennox−Gastaut
syndrome. The antiepileptic effect of LAM is due to the
stabilizing presynaptic neuronal membranes; moreover, LAM
inhibits sodium currents by selectively binding with the
inactivated state of the sodium channel and results in
repressing the release of the excitatory amino acid (such as,
glutamate and aspartate).14,15 LAM belongs to the bio-
pharmaceutical classification system class II drug with a pKa of
5.70. It is practically insoluble in ethanol, and the solubility of
LAM in water is only 0.17 mg/mL at 25 °C.16 Therefore, the
dissolution of LAM is the rate-limiting step for its efficient
absorption and bioavailability in the body. Different research
scientists have attempted to increase the water solubility and
dissolution of LAM to improve its therapeutic effects. The
following strategies have been employed: use of β-cyclodextrin
inclusion complexes, LAM salts, and solid dispersions of
LAM.17−20 To enhance the therapeutic efficacy of LAM, its
aqueous solubility needs to be improved. In order to achieve
this goal, we have prepared the five different pluronic micellar
formulations at three different temperatures to optimize the
solubility of LAM.
There are very limited reports in the literature on the effect
of temperature on the solubilization of hydrophobic drugs in
the pluronic micelles. Basak and Bandyopadhyay described the
encapsulation of the three drug molecules, erythromycin,
ibuprofen, and aspirin in pluronic F127 micelles using
dynamic light scattering (DLS) and fluorescence measure-
ments. They observed that the average hydrodynamic radii
(Dh) of the pluronic F127 micelles were increased upon drug
incorporation.21 Kadam et al. reported the solubilization of
the hydrophobic drug carbamazepine in pluronic micelles
(P103, P123, P84, and F127) at two different temperatures by
employing UV spectroscopy and DLS measurements. They
observed that the solubilization capacity of carbamezapine in
the pluronic micelles increased with the increase in temper-
ature and concentration of pluronics.22 Raval et al. studied the
micellar behavior of the aqueous solutions of six pluronics viz.
P84, F88, P103, P105, P123, and F127 in water and studied
the solubility of three poorly water soluble anticancer drugs,
genistein, paclitaxel, and quercetin, using UV−visible spec-
troscopy, high-performance liquid chromatography, and DLS.
All these investigated drugs showed improved solubility in
pluronic P123 and P103 micelles with the increase in
temperature and salt concentration. In vitro drug-release
profiles of these formulations demonstrated slower release of
the drugs in pluronic micelles. The in vitro cytotoxicity of the
drug-loaded pluronic micelles was studied on a breast cancer
MCF-7 cell line, which showed higher anticancer activity as
compared to the bare drug. These results show that pluronics
are promising candidates for anticancer drug delivery.23 In
contrast to these studies, the main objective of our work is to
find the relation between temperature, the structure of the
pluronics, and its drug solubilization capacity. For this
purpose, we have studied the solubilization of the hydro-
phobic drug LAM in five different pluronics micelles viz. P84
(PEO19PPO43PEO19), P85 (PEO26PPO40PEO26), F127
(PEO100PPO65PEO100), F108 (PEO133PPO50PEO133), and
F68 (PEO77PPO29PEO77) with 40, 50, 70, 80, and 80%
PEO content, respectively, at different temperatures (37, 47,
and 57 °C) using UV−visible measurements. The molecular
structures of LAM and different pluronics are presented in
Scheme 1. Hydrodynamic diameter (Dh) of the loaded and
unloaded micelles has been studied employing DLS measure-
ments. Furthermore, the effect of the temperature and LAM
solubilization in the investigated different pluronic micelles
has been adjudged employing indigenously built small-angle
neutron scattering (SANS) and the heat transfer method
(HTM).24−26 In vitro drug release studies were performed to
evaluate the relation of LAM release from these micelles with
respect to increase in the temperature.
2. RESULTS AND DISCUSSION
2.1. Solubilization of LAM. 2.1.1. Effect of Concen-
tration. The solubilization of LAM in the different pluronic
F68, F108, F127, P85, and P84 micellar solutions was
determined by UV−visible spectroscopy. The UV absorption
spectra of LAM solubilized in the F108, F127, P85, and P84
micelles were measured in the concentration range of 1−5%
w/v at 37 °C (Figure S1, Supporting Information). The UV
absorption of LAM increased significantly in all studied
pluronic solutions except for pluronic F68, implying that the
pluronic micelles are able to solubilize LAM. The difference in
behavior of pluronic F68 has been ascribed to its inability to
self-assemble at the studied concentration and temperature,
thereby, making it difficult to solubilize the drug.27,28 The
results for the solubilization capacities of the different
pluronics for LAM are summarized in Figure 1a. The
solubility pattern of the drug in the different pluronics follow
the order P84 > P85 > F127 > F108 > F68 at all % w/v.
These results can be explained by taking into consideration
the PEO effect and the PPO effect of the different pluronics.
Pluronic P84 shows higher solubilization than pluronic P85,
irrespective of the presence of almost similar PO units (43
and 40 PPO units in P84 and P85, respectively) and differing
in the presence of hydrophilic PEO units (2 × 19 and 2 × 26
PEO units in P84 and P85, respectively). On the other hand,
pluronics F127 and F108 with small difference in PO units
(65 and 50 PPO units in F127 and F108, respectively) and
Scheme 1. Molecular Structure of (a) Pluronics and (b)
LAM
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relatively larger difference in the PEO units (2 × 100 and 2 ×
133 PEO units in F127 and F108, respectively) exhibited
higher solubilization in F127 as compared to F108. The
results are a clear indication that the solubilization capacity of
the pluronic micelles decreases as the PEO units forming the
corona region increases. Our results are in agreement with the
work of Alexandridis et al., which states that the micellization
of pluronics decreases as the length of the corona increases.27
2.1.2. Effect of Temperature. The solubilization of LAM
has been studied at different temperatures, that is 37, 47, and
57 °C, in the different pluronic (P85, P84, F108, F127, and
F68) solutions. We noticed that the solubilization trend at 47
and 57 °C was the same as that observed at 37 °C (increased
in the following order P84 > P85 > F127 > F108 > F68).
However, the amount of LAM solubilized in a pluronic
micellar system increased remarkably as the temperature
increased [Figure 1b]. UV absorption spectra of LAM
solubilized in 5% w/v F68, F108, F127, P85, and P84
micelles at 37, 47, and 57 °C are shown in Figure S2
(Supporting Information). This was attributed to the increase
in the area for solubilization of LAM in the pluronic micelles
due to thermal agitation, in addition to the fact that LAM
solubility in water also increases with increase in temper-
ature.29−31 Alkhamis et al. reported similar results in case of
solubilization of the drug, gliclazide as a function of the
concentration of different amphiphiles at variable temper-
atures: 25 and 37 °C; all ionic surfactants investigated showed
higher solubilization of drugs at 37 °C as compared to 25 °C.
The influence of temperature on the amount of drug loading
also depends on whether the drug molecules solubilized inside
PEO, forming the hydrophilic corona or PPO, forming the
hydrophobic core region of the pluronic micelles.32 In one
report, there was decrease in the solubilization of hydrophobic
steroidal drugs in PEO-based surfactant micelles, when the
temperature was increased from 10 to 50 °C. The
solubilization of the drug in the PEO corona region of
micelles is the reason behind the decrease in solubility of
drugs. Upon increasing the temperature, there was dehy-
dration of the PEO region and this leads to a decrease in the
solubilizing area available for the drug. The micellar growth of
the pluronic micelles obtained as a result of increased
temperature is the driving force for the solubilization of
hydrophobic drugs that especially prefer the core region of the
micelles.33 In our case, solubility was increased with increasing
temperature and therefore, it can be concluded that most of
the LAM drug has been solubilized in the core region of the
pluronics. This micellar growth has been confirmed by the
SANS measurements (Section 2.3). It is also important to
mention that the CMT (critical micelle temperature) value of
the pluronic P84, P85, F127, F108, and F68 (at 5% w/v) is
23, 25, 19.5, 24.5, and 40 °C, respectively.27 Pluronic F127
has the lowest CMT value, and hence, the drug solubilization
capacity of this pluronic is lower than pluronic P85 and P84
that have the high CMT values. From these results, it was
concluded that the solubility of drugs is not only dependent
on the CMTs of the pluronics. Other important molecular
characteristic such as PEO content also plays an important
role in the solubilization of the drugs. The compilation of the
hydrophobic drug LAM solubilization data for a wide range of
pluronic block copolymers at different temperatures presented
in this article is, to the best of our knowledge, the most
complete in literature.
The drug loading efficiency (DLE) is the percentage of
solubilized LAM from the LAM fed in pluronic micelles
during the solubilization process and can be calculated from
the following eq 1.
=
−
×
DLE
total weight of drug solubilized weight of drug in water
weight of drug fed initially
100 (1)
The values of DLE of 1−5% w/v pluronics at 37 °C and 5%
w/v pluronics at 37, 47, and 57 °C are depicted in Figure
S3a,b respectively (Supporting Information).
The DLE of P84 is higher as compared to different
pluronics under study at all concentrations and temperatures
by virtue of its hydrophobicity. It is well established that
hydrophobicity of pluronics can be improved by increasing
the PPO content. Accordingly, P84, having a 60% PPO
content which is relatively higher than other pluronics under
study, displayed the highest DLE.34,35
The partition coefficient is a crucial parameter used for the
assessment of the micellar systems as potential drug carriers.36
The micellar/water partition coefficient can be calculated from
the photo-spectrometric results and is defined as the ratio of
the amount of drug solubilized in the micelle and the drug
Figure 1. (a) Amount of LAM solubilized in pluronic (F68, F108, F127, P85, and P84) micelles at various concentrations (1−5% w/v) at 37 °C
(b) Amount of LAM solubilized in 5% w/v pluronic (F68, F108, F127, P85 and P84) at 37, 47, and 57 °C.
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present in water at a particular amphiphilic concentration (eq
2).
= −P S S
S
tot w
w (2)
where Stot and Sw is the total solubility of LAM and solubility
of LAM in water, respectively. The partition coefficients have
been computed, depicted in Figure S4a for pluronic F108,
F127, P85, and P84 micelles in the concentration range of 1−
5% w/v at 37 °C and are shown in Figure 2a for 5% F68,
F108, F127, P85, and P84 at different temperature viz. 37, 47
and 57 °C. It was observed that the value of the partition
coefficient increased by increasing the temperature among all
pluronics. The highest value of the partition coefficient was
noted in P84 micelles at all temperatures, confirming the
better partitioning of solubilized LAM in these micelles
compared to other investigated pluronic micelles. Higher
partitioning of LAM in P84 micelles at all temperatures
revealed the higher drug solubilization in the core of these
micelles by inducing a favorable hydrophobic environment
compared to other investigated pluronic micelles.37
The standard free energy of solubilization (ΔG°) can be
calculated from the partition coefficient and is represented by
the following expression 3
Δ ° = −G RT Pln (3)
where R denotes the gas constant (J/mol), T is the
temperature (in Kelvin), and P is the partition coefficient.
The ΔG° value depicts the Gibbs free energy of transfer of 1
mol of the drug in the micellar phase. The ΔG° values are
depicted in the Figure S4b for pluronic F108, F127, P85, and
P84 micelles in the concentration range of 1−5% w/v at 37
°C and shown in Figure 2b for 5% F68, F108, F127, P85, and
P84 at different temperature viz. 37, 47, and 57 °C. Figure 2b
reveals that the values of ΔG° are negative except pluronic
F68 at 37and 47 °C, showing that the process of LAM
solubilization in pluronic micelles is spontaneous and transfer
of water molecules from the micellar core induces a more
hydrophobic environment.38−40 The positive ΔG° values of
pluronic F68 might be due to the inability of F68 to form the
micelles at the concentration and temperature (37 and 47 °C)
being studied.
2.2. Dynamic Light Scattering. DLS experiments were
performed to find the hydrodynamic diameter (Dh) of
pluronic micelles as a function of temperature increase as
depicted in Figure 3a,b for the Dh of aqueous solutions of 5%
w/v P84 and F127 at increasing temperatures 37, 47, and 57
°C. Dh of aqueous solutions of 5% w/v P85 and 5% w/v F108
and F68 at increasing temperatures 37, 47, and 57 °C are
presented in Figure S5a−c (Supporting Information),
respectively. In the case of hydrophobic pluronics, viz. P84
and P85, the micellar size was observed to increase with
increasing the temperature, which revealed that aggregation is
stimulated by the increase in temperature.
At 37 °C, the Dh of P84 micelles is 13.54 nm, but at the
temperature 47 and 57 °C, Dh of P84 micelles increased from
Figure 2. (a) Micellar/water partition coefficient (P) of different pluronic (F68, F108, F127, P85, and P84) micelles at various concentrations
(1−5% w/v) solubilized at 37, 47, and 57 °C (b) Gibbs free energy of solubilization (ΔG°) 5% w/v pluronic (F68, F108, F127, P85, and P84)
solubilized at 37, 47, and 57 °C.
Figure 3. Intensity weighed size distribution profiles of pluronic micelles at 37, 47, and 57 °C (a) P84 and (b) F127.
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13.54 to 18.16 nm and 37.54 nm, respectively; hydrophobic
pluronic P85 exhibits similar increase in Dh of micelles.
Pluronics F127 and F108 formed loosely packed micelles
involving few monomers, so an increase in temperature results
in the removal of water and formation of more closely packed
micelles with altogether decrease in the Dh of the micelles. In
the case of very hydrophilic pluronic F68, different peaks
correlating to micelles, clusters, and unimers are present at 37
°C. Increase in the temperature, decreases the polydispersity
and makes the unimers and clusters disappear, which results in
the single micellar peak. Dh of 5% w/v P84 and F127, LAM
loaded and unloaded micelles in aqueous solution at 37, 47,
and 57 °C were measured and are depicted in Figure 4a,b,
respectively.
DLS plots of P85, F108, and F68 are depicted in Figure
S6a−c (Supporting Information). The micelle size of P85 at
37, 47, and 57 °C was 11.83, 13.76, and 17.59 nm,
respectively, but after incorporation of LAM, it increases to
13.36, 16.13, and 17.59 nm, respectively. The micelle size of
F108 at 37, 47, and 57 °C was 32.67, 29.33, and 27.44 nm,
respectively, but after incorporation of LAM, it increases to
35.39, 32.53, and 32.05 nm, respectively. The micelle size of
F68 at 47 and 57 °C was 8.66 and 8.99 nm, respectively, but
after incorporation of LAM, it increases to 9.98 and 10.10 nm,
respectively.
2.3. SANS Measurements. Micellar structure of the 5%
w/v pluronics, viz. F68, F108, F127, P85, and P84 were
obtained from SANS measurements at different temperatures:
37, 47, and 57 °C. Scattering curves of pluronic P84 and F68
are presented in Figure 5a,b respectively, and pluronic P85,
F127, and F108 are presented in Figure S7a−c (Supporting
Information), respectively. At 37 °C, the SANS distribution
curves of all pluronics show the existence of correlation peaks
which arise because of the hard sphere repulsion between the
micelles except pluronic F68.41 The presence of unimers was
only observed in the pluronic F68 at 37 °C due to the high
CMT value of F68 (CMT of 5% w/v 68 = 40 °C).42 The
value of aggregation number (Nagg) is higher in the pluronic
P84 than that in P85, F127, and F108. The higher Nagg value
of hydrophobic pluronic P84 is attributed to the minimal
stability of this pluronic in water as compared to other
investigated pluronics.43 The higher aggregation number of
P84 is responsible for its larger hard sphere radii (RHS = 82.0)
than P85 (RHS = 71.9). Conversely, the hard sphere radius
values are higher in hydrophilic pluronics, F108 (RHS = 102.5)
and F127 (RHS = 102.0) than in pluronic P84, which signifies
the more intermicellar interaction of F108 and micelles than
that of P84 due to the longer corona region. Volume fraction
(ϕ) values of hydrophilic pluronics, F127 (ϕ = 0.158) and
F108 (ϕ = 0.142) are higher as compared to the hydrophobic
pluronics P84 (ϕ = 0.089), and P85 (ϕ = 0.098) signifies the
greater D2O penetration in the hydrophilic corona and core
region of these hydrophilic pluronics (F108 and F127).44
Various key parameters from the model for the SANS
measurements viz. core radius (Rc), polydispersity, hard
sphere radius (RHS), volume fraction (ϕ), and aggregation
number (Nagg) are tabulated in Table 1. The increase in
temperature from 37 to 47 °C and 57 °C persuades the
increase of the core radius (Rc) and the aggregation number
(Nagg). There is evidence to suggest a decrease in the hard
sphere radius of hydrophilic pluronics (F108 and F127) when
temperatures increased from 37 to 57 °C, conferring the
removal of water from the corona region. Increase in the hard
sphere radius of the hydrophobic pluronics (P84 and P85) as
increase in the temperature (37−57 °C) is due to the increase
in the aggregation numbers of these hydrophobic pluronics. In
the case of pluronic P84, volume fraction (ϕ) decreases as the
Figure 4. Intensity weighed size-distribution profiles for empty and
LAM-loaded pluronic micelles (a) P84 and (b) F127 measured by
DLS.
Figure 5. SANS data pattern (with error bars in experimental data) for (a) 5% w/v pluronic P84 (b) 5% w/v pluronic F68 at 37, 47, and 57 °C.
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temperature is increased. At 37 °C, the volume fraction (ϕ)
was 0.089 and this falls to (ϕ) = 0.081 at 47 °C and (ϕ) =
0.060 at 57 °C. A similar decrease was also observed in the
other investigated pluronics except F68. The unimers of F68
converted into the micelle with volume fraction (ϕ) = 0.065
at 47 °C, and at 57 °C, aggregation of these micelles was
increased but volume fraction was also increased from (ϕ) =
0.065−0.140. The volume fraction of F68 micelles increases,
and the dehydrating effects of the rise of temperature can be
ascribed to the transformation of remaining F68 unimers to
contribute to form more micelles.45 At 57 °C, pluronic P84
with 40% PEO content converted from spherical micelles to
prolate ellipsoidal micelles. The correlation peak tends to be
weak in the scattering curve at 57 °C and cannot be explained
employing a spherical shape micelles-based model.46,47 At
higher temperature, the aggregation number (Nagg) increases,
Table 1. Various Key Model Parameters: Core Radius (Rc), Polydispersity, Hard Sphere Radius (RHS), Volume Fraction (ϕ),
and Aggregation Number (Nagg) for 5% w/v Pluronic (F68, F108, F127, P85, and P84) at 37, 47, and 57 °C before and after
Solubilization of LAM
system
temperature
(°C)
core radius Rc
(nm) polydispersity Σ
hard sphere radius RHS
(nm)
volume
fraction ϕ
aggregation number
Nagg
5% w/v P84 37 5.21 0.19 8.20 0.089 159
47 5.65 0.19 8.82 0.081 203
57 a = 13.5, b = 5.15 0.19 8.90 0.060 403
5% w/v P84 + LAM drug 37 5.18 0.19 8.30 0.095 156
47 5.54 0.19 8.85 0.093 191
57 a = 12.8, b = 5.13 0.19 8.95 0.065 360
5% w/v P85 37 4.47 0.18 7.19 0.098 98
47 4.82 0.18 7.52 0.097 122
57 5.10 0.18 7.90 0.094 145
5% w/v P85 + LAM drug 37 4.45 0.18 7.23 0.098 96
47 4.79 0.18 7.63 0.098 120
57 5.04 0.18 7.95 0.094 140
5% w/v F127 37 5.44 0.38 10.20 0.158 108
47 5.78 0.34 10.10 0.151 130
57 5.94 0.31 10.10 0.138 141
5% w/v F127 + LAM drug 37 5.42 0.38 10.25 0.158 107
47 5.76 0.34 10.20 0.151 129
57 5.90 0.30 10.15 0.138 138
5% w/v F108 37 4.79 0.49 10.25 0.142 96
47 5.33 0.46 10.20 0.140 132
57 5.82 0.40 10.10 0.130 173
5% w/v F108 + LAM drug 37 4.67 0.48 10.30 0.145 89
47 5.24 0.44 10.30 0.143 126
57 5.66 0.39 10.20 0.140 159
5% w/v F68 37 Rg = 2.11 nm (unimer)
47 1.98 0.55 7.35 0.065 11
57 3.88 0.49 7.10 0.130 88
5% w/v F68 + LAM drug 37 Rg = 2.08 nm (unimer)
47 2.13 0.56 7.40 0.082 14
57 3.37 0.46 7.25 0.140 57
Figure 6. SANS data pattern (with error bars in experimental data) for (a) P84 and (b) F68, 5% w/v in the absence and presence of LAM drug
37, 47, and 57 °C.
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Nagg ≈ 159 at 37 °C to Nagg ≈ 203 at 47 °C and Nagg ≈ 403 at
57 °C, leading to an increase in the micelle core radius. When
the length of the core region exceeds the stretched length of
the PEO corona region of the pluronic micelles, it tends to
shape conversion from spherical to prolate ellipsoidal micelles.
It is reported in the literature that when the temperature
increases, the aspect ratio also increases, which results in
anisotropic growth and change in morphology of micelles to
worm-like and cylindrical structures.48,49
Another important reason behind this kind of behavior is
change in the PEO region into a less polar form with increase
in temperature; moreover, PEO region of the P84 micelle
interacts less favorably with water molecules. A weak
interaction between the PEO region and water molecules at
57 °C results in the higher packing density at the PEP−PPO−
PEO interface, which favors the morphological conversion of
spherical pluronic micelles to prolate ellipsoidal micelles.47
The results showed no structural transformations of other
pluronics due to insignificant increase in the aggregation
number (Nagg). In case of pluronic P85 with 50% PEO
content, Nagg ≈ 98 at 37 °C to Nagg ≈ 122 at 47 °C and Nagg
≈ 145 at 57 °C, in pluronic F127 with 70% PEO content, Nagg
≈ 108 at 37 °C to Nagg ≈ 130 at 47 °C and Nagg ≈ 141 at 57
°C, in pluronic F108 with 80% PEO content Nagg ≈ 96 at 37
°C to Nagg ≈ 132 at 47 °C and Nagg ≈ 173 at 57 °C, in
pluronic F68 with 80% PEO content Nagg ≈ 11 at 47 °C to
Nagg ≈ 88 at 57 °C. A decrease in the interactions between
water and pluronic P84 on an increase in temperature was the
main reason for the increase in the aggregation number.
Instead of the longer corona region of the other investigated
micelles enable to retain the interactions of pluronics with
water.
Scattering curves of pluronics P84 and F68 in the presence
of LAM are shown in Figure 6a,b, respectively; pluronic P85,
F127, and F108 in the presence of LAM are presented in
Figure S8a−c (Supporting Information), respectively. The
scattering data from solutions of all pluronic micelles show
features that are observed in the absence of the LAM drug.
The SANS results evidenced no change in the scattering
features in the presence of LAM. However, in the absence of
LAM, the scattering intensity decreased at low values of q
region, when compared to data from pluronic micelles, in the
presence of LAM. However in the absence of LAM, the
scattering intensity decreased at low values of q region, when
compared to data from pluronic micelles. These observations
indicate that the drug affects either the aggregation number or
size but does not affect the shape of pluronic micelles. SANS
experiments on micellar solutions in the presence of LAM
suggest that the number density of micelles increases as the
pluronic micelle aggregation number decreases. This may be
attributed to the rise in the micellar volume fraction due to
the presence of the hydrophobic drug LAM.50 Upon the
addition of LAM, the size of cores and the coronas of the
micelles increased; the values are tabulated in Table 1. A
Figure 7. Resistance vs temperature profiles of pluronic micelles at variable temperature (a) P84 and (b) F127 (c) P84 in the preseance of the
LAM drug (d) F127 in the presence of the LAM drug.
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significant decrease in the aggregation number of the pluronic
micelles indicates that in the presence of the LAM drug,
micelle formation occurred even at lesser pluronic monomers.
The concentration of pluronic F108, F127, P85, and P84 are
above the cmc values; in fact, the remaining monomers of
pluronics participate in the formation of new micelles.
Prescott et al. also explored the effect of addition of
flurbiprofen drug, cosolvent, and temperature on the pluronic
micellization using SANS measurements. The scattering
pattern obtained from SANS measurements revealed the
attractive interactions in the micelles and/or the morpho-
logical change in the micelles at the higher flurbiprofen
concentrations (1% w/v). These results demonstrate that
these important factors must be considered carefully for
clinical or industrial applications, such as effect of various
environmental conditions, including the presence of cosolvent,
temperature, hydrophobic species, such as drug molecules,
impurities, and hydrophobicity of the pluronics on the
micellization of pluronics.51
2.4. HTM Measurements. The working temperature
range was chosen on the basis of the morphological transitions
observed in pluronic micelles with SANS measurements. The
heat transfer resistance, Rth, was calculated using eq 4 given
below
= −R T T
Pth
1 2
(4)
Here, T1 and T2 is the temperature of the copper block and
temperature measured by the thermocouple that is placed in
the liquid at 1.7 mm above the copper black, and P is the
power applied. Rth measurements of pluronic P84 and
pluronic F127 are displayed in Figure 7a,b, respectively.
The noise in the Rth signal is due to small fluctuations of the
power input related to the PID controller. It is noteworthy
that irreversible changes on the electrode surface are observed
as a decrease in the Rth upon heating. Moreover, the
temperatures at which the Rth drops are detected correspond
well to the main phase-transition temperature observed by the
SANS measurement: the pretransitional behavior starts at 55.0
°C, and the transition is finished at 58 °C (Figure 7a),
intimating that the modification in Rth correlates to a phase
change between spherical micelles and the prolate ellipsoidal
micellar states upon heating (Rth value). At the temperature
where morphological changes occur (spherical micelles to
prolate ellipsoidal micelles), there is decrease in the surface
area of the micelles due to the elongated structure that
increase the movement of the current resulting in the decrease
in the thermal resistance value. There are no additional
morphological changes observed in the next temperature
cycle. In the case of pluronic F127, there is a continuous
decrease in the Rth upon heating, whereas the Rth increased to
the same value upon cooling. In this case, there is no drop in
the Rth value, confirming that there are no morphological
changes occurring on the surface. The LAM--loaded pluronic
P84 micelles shown in Figure 7c demonstrate a drop in the
Rth starting at 52 °C in the first heating cycle that ends at 58
°C, which is not observed in any later heating and cooling
cycles. When comparing the temperature at which transition
starts between the LAM-loaded pluronic P84 micelles and
unloaded pluronic P84, there is a difference of 3 °C, favoring
the morphological changes to occur at a lower transition
temperature in the presence of LAM. LAM-loaded F127
micelles (Figure 7d) also does not show any significant
difference in the Rth value, which corresponds to a consistent
morphology of the micelles.
2.5. In Vitro Drug Release. The release of LAM from
pluronic formulations at 37 and 57 °C is presented in Figure
8a,b, respectively. The figure depicts that the drug release
starts with an initial burst followed by a slow release of LAM
from the formulations prepared at 37 °C was 2, 1, 0.5, and 0.5
h faster than formulations prepared at 57 °C in pluronic P84,
P85, F127, and F108, respectively. LAM-loaded hydrophilic
pluronics of F108 and F127 that are prepared at 37 °C
showed 100% drug release in 2 and 2.5 h, respectively.
However, a slower release rate was seen in the case of loaded
hydrophobic pluronics P84 and P85 as they showed 90%
LAM release in 4.5 and 5 h, respectively, because most of the
LAM was solubilized in the core of these micelles. Five
different models, viz. zero-order kinetics, first-order kinetics,
Higuchi kinetics, the Hixson−Crowell model, and the KP
model, were used to evaluate the data of drug release.52 The
most fitted model was selected based on comparing the
coefficient of determination. To find the release phenomenon
of LAM from the pluronic micelles, correlation coefficient and
rate constant were computed for all five models. From the R2
values, it was ascertained that for the LAM release profiles of
formulations solubilized at 37 °C, the best fit model was the
Hixson model for all pluronic micelles, except the F108
micelle for which the best fitted model was KP model; the
values are tabulated in Table 2. According to the KP equation,
Figure 8. In vitro release of LAM from different pluronic micelles at 37 °C (a) formulations solubilized at 37 °C (b) formulations solubilized at
57 °C.
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0.5 ≤ n (diffusional coefficient) is described with a Fickian
diffusion mechanism, 0.5 < n < 1.0 anomalous (non-Fickian)
diffusion, 1.0 = n case II transport, and n > 1.0 with super case
II transport.53,54 The diffusional coefficient (n) value less than
0.5 in case of F108 suggested that the release follows the
Fickian diffusion. Whereas in case of the formulations
solubilized at 57 °C, the best-fitted model was KP for all
pluronic micelles except F127 micelles, which followed the
Hixson model values, which are tabulated in Table 3. The
value of n observed in the best fitted model for F68, F108,
P85, and P84 pluronic micelles was observed to be more than
0.5, indicating anomalous (non-Fickian) diffusion.
3. CONCLUSIONS
In summary, we have presented LAM solubilization in five
different pluronics, viz. P84, P85, F127, F108, and F68, using
UV−visible spectroscopy. The solubilization in all pluronics
was enhanced by increasing the temperature, which changes
the polarity of the micelles leading to dehydration and an
increase in the aggregation number. Different solubilization
parameters such as the drug loading capacity, partition
coefficient, and standard free energy of solubilization (ΔG°)
were determined. Among all investigated pluronics, P84 has
the best solubilization capacity in the temperature range, 37−
57 °C. SANS experiments revealed that pluronic P84 micelles
converted in prolate ellipsoidal micelles from spherical
micelles at 57 °C. This was confirmed by DLS and HTM
and is due to higher hydrophobicity of P84 compared to other
investigated pluronics. The SANS results showed that the
aggregation number increases in hydrophobic pluronic P84 as
the temperature is increased and that is the driving force for
the morphological changes in the micelles. HTM results
revealed that the conversion of the spherical micelles to
prolate ellipsoidal micelles starts at 55 °C and ends at 58 °C.
However, the hydrophilic pluronic F127 does not show any
significant change in the Rth value, confirming that no
morphological changes occur as a function of temperature.
In vitro drug release revealed that the release behavior of
LAM can be modulated by simply changing the temperature
for preparation of pluronic micelle formulation. Therefore,
this work opens many new areas to modulate the drug-loading
capacity of the hydrophobic drug in the different pluronic
micelles by varying the temperature and drug release behavior.
For the first time, we have reported the use of HTM to
determine morphological changes of thermoresponsive
micelles.
4. MATERIALS AND METHODS
4.1. Materials. Pluronics P84, P85, F127, F108, F68, and
LAM, with purities of ≥98% were procured from Sigma-
Aldrich. All other chemicals used were of analytical grade and
used without any further purification. For the preparation of
solutions, double distilled water was used.
4.2. Methods. 4.2.1. Solubilization Study of LAM Drug.
To investigate the solubilization capacity, preweighed amounts
of LAM were added to the vials containing 5 mL of different
pluronic P84, P85, F127, F108, and F68 micellar media. The
sample vials were stirred at a temperature of 37, 47, and 57 ±
0.1 °C for 12 h after which they were filtered using a millipore
filter (0.20 μm) to remove the LAM that did not dissolve in
the micelles. The concentration of solubilized LAM in the
micelles was determined using a Shimadzu (UV-1800) UV−
vis double beam spectrophotometer. The λmax of LAM was
found to be 303 nm. Molar absorption coefficient of LAM was
5.9832 × 103 L mol−1 cm−1 as calculated from the calibration
curve. The pluronic concentration was kept the same in both
the reference and the measurement cell to eliminate the effect
of the pluronics on the UV absorbance. Molar absorption
coefficient has been used to determine the amount of LAM
solubilized in the pluronic micelles.
4.2.2. DLS Measurements. The hydrodynamic diameter
(Dh) of pluronic micelles in the presence and absence of LAM
was measured using a Malvern Zetasizer Nanoseries Nano-ZS
instrument equipped with He−Ne laser (λ = 632.8 nm) at 37,
47, and 57 ± 0.1 °C at a scattering angle of 173°. All samples
were filtered with millipore filter (0.20 μm) to avoid the
interference of contaminants.
4.2.3. SANS Measurements. The SANS measurements
were carried out on an indigenously built SANS instrument
operating at the Dhruva reactor, Bhabha Atomic Research
Centre (BARC), Mumbai, India.24,25 The mean wavelength of
the monochromatized beam was 5.2 Å−1 [wavelength
resolution (Δλ/λ) of approximately 15%] and was equipped
with a linear position sensitive detector (angular range 0.5−
Table 2. Rate Constants and Correlation Coefficients Using Different Kinetic Models for the Release Behavior of LAM from
Different Pluronic Formulations Solubilized at Temperature of 37 °C
zero order kinetics first order kinetics Higuchi kinetics Hixson−Crowell model KP model
system R2 K0 (h
−1) R2 K (h−1) R2 KH (h
−1) R2 K (h−1) R2 KH (h
−1) N
P84 0.871 30.72 0.795 2.099 0.958 12.86 0.965 0.251 0.948 1.675 0.544
P85 0.858 33.05 0.771 2.168 0.955 11.98 0.972 0.229 0.960 1.730 0.519
F127 0.911 23.88 0.783 2.239 0.950 7.423 0.957 −0.012 0.857 1.808 0.658
F108 0.967 39.51 0.743 2.122 0.951 4.992 0.900 0.144 0.968 1.902 0.365
Table 3. Rate Constants and Correlation Coefficients Using Different Kinetic Models for the Release Behavior of LAM from
Different Pluronic Formulations Solubilized at the Lowest Temperature (57 °C)
zero order kinetics first order kinetics Higuchi kinetics Hixson−Crowell model KP model
system R2 K0 (h
−1) R2 K (h−1) R2 KH (h
−1) R2 K (h−1) R2 KH (h
−1) N
P84 0.950 16.40 0.838 2.176 0.969 11.98 0.982 −0.052 0.986 1.388 0.742
P85 0.949 18.60 0.898 2.225 0.953 9.620 0.988 −0.098 0.990 1.546 0.700
F127 0.916 16.43 0.933 2.291 0.968 5.365 0.990 −0.207 0.957 1.616 0.963
F108 0.980 16.87 0.823 2.263 0.989 6.686 0.960 −0.298 0.997 1.761 0.692
F68 0.961 30.53 0.802 2.239 0.990 5.785 0.958 −0.079 0.992 1.853 0.522
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15°). These were used to impart Q-range from 0.018 to 0.32
Å−1. All sample measurements were carried out at 37, 47, and
57 ± 0.1 °C. Theoretical details regarding the SANS
measurements are provided as Annexure SI (Supporting
Information).
4.2.4. HTM Measurements. For the HTM measurements,
⟨111⟩ p-type silica electrodes from Sigma-Aldrich (Gilling-
ham, United Kingdom) were functionalized with 100 μL of a
micelle solution. Subsequently, these electrodes were dried at
50.0 ± 0.1 °C for 30 min and mounted on the flow cell shown
in Scheme 2, as per the flow cell design described in ref 26.
After stabilizing for 30 min at 35 °C in a phosphate-buffered
saline (PBS) solution, the temperature was increased to 70 °C
and subsequently cooled down to the starting temperature
using a constant heating or cooling rate of 11.67 °C/h. Three
of these temperature cycles were performed and after the final
run, the solution was kept at 35 °C for 30 min.
4.2.5. In Vitro LAM Release from Pluronic Micelles. In
vitro release profiles of LAM from different micelles were
evaluated using the dialysis release method. A solution of
LAM-loaded pluronic micelles (2 mL) was introduced into a
dialysis membrane bag (Himedia, molecular weight cut off
between 12 000 and 14 000) and submerged into 100 mL of a
PBS solution (pH = 7.4), which acts as release medium to
create a concentration gradient. The dialysis release system
was maintained at 37 °C with constant stirring at 250 rpm.
Samples were taken from the release medium at regular
specified time intervals, and the media was replenished with
the same volume of fresh release media. The collected samples
were filtered with 0.20 μm filters before determining the
amount of LAM release using a spectrophotometer.
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